L'economiste Dean Baker secoue un peu ses collegues sur le sujet des brevets, enfin !
Laurent http://maxspeak.org/mt/archives/001689.html << [...] The $220 billion question (current U.S. spending on prescription drugs) is where are the economists? Remember, economists are people that get high blood pressure from 10 percent tariffs on shoes or pants. When Bush put a temporary tariff on steel imports that maxed out at 30 percent, economists all over the country became apoplectic. So why is the economics profession overwhelmingly silent about drug patents, which are the equivalent of tariffs of 300 percent on average, and affect a product that is much more important to our economy and our health? We recognize that patents are a way to provide incentives for research, but where is the economic research that shows that they are the most efficient way? You won’t find it, because economists have mostly chosen to ignore the issue. [...] >> Des reponses aux objections ici : http://maxspeak.org/mt/archives/001704.html D'autres discussions : http://plumer.blogspot.com/2005_10_01_plumer_archive.html#112967594764871932 http://www.marginalrevolution.com/marginalrevolution/2005/10/should_we_confi.html Un bon papier de fond : http://www.cepr.net/publications/patents_what_are_the_issues.htm Laurent _______________________________________________ Liste de discussion FSF France. http://lists.gnu.org/mailman/listinfo/fsfe-france
